FDA Inspection 1037949 — Rinovum Subsidiary 2 LLC
The FDA completed an inspection of Rinovum Subsidiary 2 LLC on November 17, 2017 in Monroeville, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 17, 2017
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Monroeville, PA (United States)
Additional Details
Sponsor, Contract Research Organization